
Lantheus Holdings (LNTH) Stock Forecast & Price Target
Lantheus Holdings (LNTH) Analyst Ratings
Bulls say
Lantheus Holdings is well-situated to benefit from the growing trend of precision medicine in the healthcare industry, with its diverse portfolio of radiopharmaceutical products that can aid in the diagnosis and treatment of various diseases. The company's focus on partnerships and collaborations also allows for potential growth opportunities and further expansion of its product pipeline. With a successful track record and strong financials, Lantheus could see increased demand for its products and potential for future growth in the coming years.
Bears say
Lantheus Holdings is facing a dynamic and competitive environment, leading to potential share losses and a conservative guidance for FY26, as seen in the reiterated revenue and EPS outlook. While the CEO search is in its final stages, the company's current performance and stable financials provide some comfort, but the potential for volatility and uncertainty surrounding the transition remains. Additionally, the company is highly dependent on the success and growth of its key products, making it vulnerable to potential setbacks or underperformance in the future.
This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.
Lantheus Holdings (LNTH) Analyst Forecast & Price Prediction
Start investing in Lantheus Holdings (LNTH)
Order type
Buy in
Order amount
Est. shares
0 shares